Chemokine, CC Motif, Ligand 5

Alternative Names

  • CCL5
  • Small Inducible Cytokine A5
  • SCYA5
  • Regulated Upon Activation, Normally T-Expressed, And Presumably Secreted
  • RANTES
  • T Cell-Specific RANTES
  • T Cell-Specific Protein p228
  • TCP228
Back to search Result
OMIM Number

187011

NCBI Gene ID

6352

Uniprot ID

P13501

Length

8,870 bases

No. of Exons

4

No. of isoforms

1

Protein Name

C-C motif chemokine 5

Molecular Mass

9990 Da

Amino Acid Count

91

Genomic Location

chr17:35,871,490-35,880,359

Gene Map Locus
17q12

Description

This gene is one of several chemokine genes clustered on the q-arm of chromosome 17. Chemokines form a superfamily of secreted proteins involved in immunoregulatory and inflammatory processes. The superfamily is divided into four subfamilies based on the arrangement of the N-terminal cysteine residues of the mature peptide. This chemokine, a member of the CC subfamily, functions as a chemoattractant for blood monocytes, memory T helper cells and eosinophils. It causes the release of histamine from basophils and activates eosinophils. This cytokine is one of the major HIV-suppressive factors produced by CD8+ cells. It functions as one of the natural ligands for the chemokine receptor chemokine (C-C motif) receptor 5 (CCR5), and it suppresses in vitro replication of the R5 strains of HIV-1, which use CCR5 as a coreceptor. [From RefSeq]

Epidemiology in the Arab World

View Map
Variant NameCountryGenomic LocationClinvar Clinical SignificanceCTGA Clinical Significance Condition(s)HGVS ExpressionsdbSNPClinvar
CCL5, -28C-GLebanonPathogenicBenignCCL5, -28C-G12739
CCL5, -403G-ALebanonBenignCCL5, -403G-A

Other Reports

Bahrain

Ansari et al. (2006) carried out a prospective study on 58 patients with lower gastrointestinal symptoms at the Bahrain Specialist Hospital from July 2004 to April 2005 to compare RANTES expression between intestinal biopsy specimens of patients with Crohn's disease and those with ulcerative colitis. In this study, endoscopic colonic biopsy specimens were taken from every patient and subjected to routine hematoxylin and eosin staining examination by light microscopy, immunohistochemistry for examination of RANTES protein expression by light microscopy and in situ hybridization for examination of RANTES mRNA expression by light microscopy. Of the patients, 40 had IBD (21 had Crohn's disease and 19 had ulcerative colitis) and 15 were controls with normal colonic biopsy results or non-inflammatory lesions and three had colonic inflammatory lesions other than IBD. Ansari et al. (2006) found that RANTES expression in lymphocytes or histiocytes was significantly higher (p = 0.04) in new patients with ulcerative colitis than in those with Crohn's disease analyzed by immunohistochemistry (IHC).

United Arab Emirates

Ellis et al. (2005) conducted a prospective observational study of hematological-malignancy patients undergoing chemotherapy. During systemic inflammatory response syndrome/sepsis or severe sepsis/septic shock mean concentrations of RANTES were 3394 or 2939 pg/ml, respectively, significantly lower than those prior to fever (6031 pg/ml) (P < 0.01) or at bone-marrow recovery (6433 pg/ml, P < 0.001). Levels during febrile-bacteremia were lower compared with febrile-non-bacteremia (3022 pg/ml vs. 5111 pg/ml, respectively, P < 0.01). Sixty-three of 67 infection episodes resolved despite low RANTES concentrations, suggesting RANTES is not a prerequisite for recovering from most infection events. However, in four patients dying from septic shock associated with aspergillosis, candidosis, pneumonia or infectious colitis, RANTES concentrations were persistently and extremely low (1629 pg/ml), compared with four matched patients who recovered (6780 pg/ml).

© CAGS 2024. All rights reserved.